Depression Neuromodulation trials

Feasibility of Home-Based Intermittent 60Hz Light Therapy for Major Depressive Disorder (MDD)

RecruitingNCT07111390Phase: NAStarted 2025-08-18

Summary

This pilot study evaluates the feasibility, safety, and preliminary efficacy of home-based 60Hz intermittent light therapy in adults with a major depressive episode (MDE). Participants will be randomi

Eligibility

Sex
ALL
Min Age
24 Years
Max Age
65 Years

Locations

NYU Langone HealthNew York, New York, United States

View full study details on ClinicalTrials.gov

clinicaltrials.gov/study/NCT07111390